These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18448972)

  • 21. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Could Epstein-Barr virus or canine distemper virus cause multiple sclerosis?
    Lincoln JA; Hankiewicz K; Cook SD
    Neurol Clin; 2008 Aug; 26(3):699-715, viii. PubMed ID: 18657722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the immunopathogenesis of multiple sclerosis.
    Yadav SK; Mindur JE; Ito K; Dhib-Jalbut S
    Curr Opin Neurol; 2015 Jun; 28(3):206-19. PubMed ID: 25887768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging concepts in pediatric-onset multiple sclerosis and related disorders.
    Tenembaum SN
    Curr Opin Pediatr; 2010 Dec; 22(6):726-30. PubMed ID: 20885330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
    Markovic-Plese S
    Neuroscientist; 2009 Jun; 15(3):225-31. PubMed ID: 19297658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent prognosis on etiology and pathophysiology of multiple sclerosis].
    Niino M
    Nihon Rinsho; 2013 May; 71(5):807-10. PubMed ID: 23777086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.
    Lopez-Diego RS; Weiner HL
    Nat Rev Drug Discov; 2008 Nov; 7(11):909-25. PubMed ID: 18974749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus and multiple sclerosis.
    Pohl D
    J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect.
    Poser CM
    Clin Neurol Neurosurg; 2006 Mar; 108(3):227-33. PubMed ID: 16406307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protecting axons in multiple sclerosis.
    Wilkins A; Scolding N
    Mult Scler; 2008 Sep; 14(8):1013-25. PubMed ID: 18632772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive immunity in inflammatory bowel disease: state of the art.
    Kaser A; Blumberg RS
    Curr Opin Gastroenterol; 2008 Jul; 24(4):455-61. PubMed ID: 18622159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.
    Lim ET; Giovannoni G
    Expert Rev Neurother; 2005 May; 5(3):379-90. PubMed ID: 15938671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10.
    Hayes CE; Donald Acheson E
    Med Hypotheses; 2008; 71(1):85-90. PubMed ID: 18387750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?
    Weiner HL
    Ann Neurol; 2009 Mar; 65(3):239-48. PubMed ID: 19334069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD16+ gammadelta T cells mediate antibody dependent cellular cytotoxicity: potential mechanism in the pathogenesis of multiple sclerosis.
    Chen Z; Freedman MS
    Clin Immunol; 2008 Aug; 128(2):219-27. PubMed ID: 18501678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)].
    Fernández-Fernández O; Alvarez-Cermeño JC; Arbizu-Urdiain T; Arroyo-González R; Arnal-García C; Casanova-Estruch B; Calles-Hernández MC; Coret-Ferrer F; Comabella M; García-Merino JA; de Las Heras V; Izquierdo G; Meca-Lallana JE; Muñoz-García D; Olascoaga J; Oreja-Guevara C; Prieto JM; Rodríguez-Antigüedad A; Tintoré M; Montalban X;
    Rev Neurol; 2011 Feb; 52(4):227-38. PubMed ID: 21312169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genetics of multiple sclerosis.
    Lin R; Charlesworth J; van der Mei I; Taylor BV
    Pract Neurol; 2012 Oct; 12(5):279-88. PubMed ID: 22976058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L; Conti L; Clerico M; Boselli D; Contessa G; Ripellino P; Ferrero B; Eid P; Novelli F
    Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Susceptibility to multiple sclerosis and T-lymphocyte receptor genes. A synthetic review].
    Bongioanni P; Fioretti C; Meucci G
    Minerva Med; 1995 Dec; 86(12):543-9. PubMed ID: 8684681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B vaccine and risk of multiple sclerosis.
    DeStefano F; Verstraeten T; Chen RT
    Expert Rev Vaccines; 2002 Dec; 1(4):461-6. PubMed ID: 12901584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.